Are you Dr. Farrell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 38 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Silver Spring, MD 20993Phone+1 301-796-2330
Summary
- Dr. Ann Farrell, MD is a hematologist in Silver Spring, Maryland. She is currently licensed to practice medicine in Massachusetts and Connecticut.
Education & Training
- UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1993 - 1996
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1986 - 1989
- Rush Medical College of Rush University Medical CenterClass of 1986
Certifications & Licensure
- MA State Medical License 1993 - 2026
- CT State Medical License 1989 - 1999
Publications & Presentations
PubMed
- 13 citationsResponse Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analy...Kelly J Norsworthy, Xin Gao, Chia-Wen Ko, E Dianne Pulte, Jiaxi Zhou
Journal of Clinical Oncology. 2022-03-10 - 54 citationsSystematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public HealthElaine Chang, Lorraine Pelosof, Steven Lemery, Yutao Gong, Kirsten B. Goldberg
The Oncologist. 2021-10-01 - 35 citationsFDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 MutationE. Dianne Pulte, Kelly J. Norsworthy, Yaping Wang, Qing Xu, Hisham Qosa
Clinical Cancer Research. 2021-02-25
Press Mentions
- FDA Approves Hympavzi for HemophiliaOctober 15th, 2024
- FDA Approves First Once-Weekly Drug Treatment Regimen for HemophiliaOctober 11th, 2024
- FDA Approves Oral Agent for Anemia in Dialysis PatientsFebruary 15th, 2023
- Join now to see all